top of page


News​

Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Manageme
Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Apr 11, 2019

Alpha DaRT: Turning alpha radiation into a high-precision cancer therapy
Radiation therapy, the use of high-energy particles or waves, such as x-rays, gamma rays, electrons, or protons, has long been used to...
Jan 31, 2019


Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and
Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Nov 7, 2018


Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Sep 5, 2018


New Radiotherapy Approach Deemed Safe for Clinical Trials
The Massachusetts Radiation Control Program (RCP), in conjunction with the U.S. Nuclear Regulatory Commission (NRC), has approved Alpha...
Aug 23, 2018


Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors with Alpha Radiation
Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors,...
Jul 17, 2017
bottom of page